Innate Pharma SA Current Deferred Income Including Current Contract Liabilities
Innate Pharma SA (IPHA) had Current Deferred Income Including Current Contract Liabilities of EUR 2.83 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities · last filed 2026-04-01
- 2025-12-31: Current Deferred Income Including Current Contract Liabilities 2.83M EUR.
- 2025-06-30: Current Deferred Income Including Current Contract Liabilities 563.00K EUR.
- 2024-12-31: Current Deferred Income Including Current Contract Liabilities 616.00K EUR.
- 2024-06-30: Current Deferred Income Including Current Contract Liabilities 2.80M EUR.
| Period end | Current Deferred Income Including Current Contract Liabilities |
|---|---|
| 2025-12-31 | 2.83M EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 563.00K EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 616.00K EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 2.80M EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 5.87M EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 5.05M EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 6.56M EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 9.09M EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 12.50M EUR 20-F · filed 2024-04-04 |
| 2020-12-31 | 11.30M EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 48.77M EUR 20-F · filed 2022-04-04 |